Madison Clarke
The Black Death, or the bubonic plague, was responsible for the deaths of millions of Europeans during the Middle Ages. It is caused by the Yersinia pestis bacterium, which is spread by fleas on rodents and other animals. While there is currently no cure for the plague, there have been efforts to develop a vaccine since 1895. Early vaccines were found to be ineffective against pneumonic plague, so live, attenuated vaccines and recombinant protein vaccines have been developed. However, there is still limited data and evidence regarding the efficacy of modern plague vaccines, and they are not commercially available.
| Characteristics | Values |
|---|---|
| Is there a vaccine for the plague? | Yes, there is an existing plague vaccine based on formalin-killed whole bacterial cells. However, it is not in common use due to side effects such as fever, headache, and pain, which increase in severity with repeated doses. |
| Regions with available vaccines | The vaccine is primarily recommended for healthcare workers, disaster relief workers, and laboratory personnel working directly with Y. pestis in endemic areas. The countries of the former Soviet Union and China also continue to use LWC-based vaccines. |
| Vaccine development | The idea to develop a vaccine against the plague began in 1895 by Alexandre Yersin, who investigated immunity against Y. pestis in small animal models. The first plague vaccine was later developed by bacteriologist Waldemar Haffkine in 1897. |
| Vaccine distribution | Between 1897 and 1925, it is estimated that 26 million doses of Haffkine's anti-plague vaccine were distributed from Bombay, reducing plague mortality by 50%-85%. |
| Current vaccine status | There is no preventative vaccine available for the plague at present. New plague vaccines are in development but are not expected to be commercially available soon. |
| Vaccine efficacy | The Cochrane Collaboration found no studies of sufficient quality to determine the efficacy of modern plague vaccines. More trials are needed to generate additional evidence of their long-term effects. |
| Types of vaccines | Killed Whole Cell (KWC)-based vaccines, Live Whole Cell (LWC)-based vaccines, subunit vaccines, recombinant protein vaccines, attenuated vaccines, and plant-derived vaccines have all been explored. |
| Vaccine safety | Safety evidence for plague vaccines is limited, but they are generally well-tolerated, with only mild to moderate adverse events reported. However, LWC-based vaccines have been associated with adverse effects and a lack of long-term immunity. |
Explore related products
What You'll Learn
- The first plague vaccine was developed by bacteriologist Waldemar Haffkine in 1897
- Haffkine's vaccine reduced plague mortality by 50-85% in British India
- There is no plague vaccine commercially available in the US
- The plague is caused by the Yersinia pestis bacterium, spread by fleas on rodents
- The plague is still endemic in many parts of the world
The first plague vaccine was developed by bacteriologist Waldemar Haffkine in 1897
The first plague vaccine was developed by the bacteriologist Waldemar Haffkine in 1897. Haffkine, a Russian Jew who had trained in Odessa and honed his skills in Paris, travelled to Calcutta in 1894 in search of cholera. However, he faced scepticism and resistance from the British medical establishment and the Indian public.
In January 1897, Haffkine tested his plague vaccine on himself, injecting himself with 10cc of his preparation—a much higher dose than the 3cc intended for human use. He experienced a severe fever but recovered after several days. Later that month, a plague outbreak occurred at Bombay's Byculla House of Correction, and Haffkine carried out controlled tests, inoculating 147 prisoners and leaving 172 untreated. There were 12 cases and six deaths among the untreated group, compared to just two cases and no deaths among those inoculated.
Following the success of these tests, Haffkine conducted a massive inoculation programme in British India. Between 1897 and 1925, an estimated 26 million doses of his anti-plague vaccine were sent out from Bombay, reducing plague mortality by 50–85%. Haffkine's inoculation scheme was the first effective prophylactic vaccination for a bacterial disease in humans.
In 1925, the Bombay Government renamed the laboratory as the Haffkine Institute in tribute to the pioneering bacteriologist. Haffkine died in Lausanne, Switzerland, in 1930, aged 70.
Smallpox Vaccine: Did I Get It as a Kid?
You may want to see also
Explore related products
Haffkine's vaccine reduced plague mortality by 50-85% in British India
The Black Death, or the plague, is caused by Yersinia pestis, a deadly bacterium. Plague vaccines have been considered effective in dealing with the plague because they prevent the disease rather than simply treating it. The first plague vaccine was developed by bacteriologist Waldemar Haffkine in 1897. He tested the vaccine on himself to prove its safety.
Haffkine's vaccine was a bacterial suspension of killed Y. pestis injected as a preventive during a plague epidemic in Bombay (now Mumbai), India. It was not perfect and had numerous unpleasant side effects, but it did reduce plague mortality by 20 to 30 percent. Some sources state that the vaccine reduced plague mortality by 50-85%.
Haffkine conducted a massive inoculation program in British India, and it is estimated that 26 million doses of his anti-plague vaccine were sent out from Bombay between 1897 and 1925. This preparation was tested in humans in India, with over 20 million doses being given, resulting in reduced incidence and mortality in immunized persons.
In 1902, 19 people in Mulkowal, Punjab, died from tetanus poisoning as a consequence of the anti-plague vaccination. Haffkine was blamed unjustly and was exonerated only in 1907 following a campaign spearheaded by Ronald Ross. In tribute to the great bacteriologist, the Bombay Government renamed the laboratory as the Haffkine Institute in 1925.
In the 1930s, scientists in Madagascar and Java produced a vaccine based on a live attenuated strain of Y. pestis. Both Haffkine's vaccine and the new attenuated strain vaccine continued to be used, with the United States relying on the former and the French, Russians, and Chinese relying on the latter. Both vaccines had problems and could be fatal, although recent administration techniques have decreased the side effects.
Vaccines: Activating Our Adaptive Defenses
You may want to see also
Explore related products
There is no plague vaccine commercially available in the US
The plague, or the Black Death, is an infection caused by the Yersinia pestis (Y. pestis) bacterium. It is spread mostly by fleas on rodents and other animals. Humans who are bitten by these fleas can contract the plague. In the United States, plague cases have been reported in several states, including New Mexico, Arizona, Colorado, California, Oregon, and Nevada.
While there have been efforts to develop a plague vaccine, there is currently no plague vaccine commercially available in the US. The CDC states that a plague vaccine is no longer available in the United States, and new plague vaccines are still in development. However, it is important to note that plague immunization methods do exist. The existing plague vaccine is based on formalin-killed whole bacterial cells, but it is not in common use due to side effects such as fever, headache, and pain that increase with repeated doses. As a result, this vaccine is only recommended for healthcare workers in endemic areas, disaster relief workers, and laboratory personnel working directly with Y. pestis.
Historically, bacteriologist Waldemar Haffkine developed a plague vaccine in 1897 and conducted a massive inoculation program in British India. Between 1897 and 1925, an estimated 26 million doses of Haffkine's anti-plague vaccine were distributed from Bombay, reducing plague mortality by 50%-85%. This vaccine was effective in inducing active specific immunity in organisms susceptible to the plague.
In addition to historical efforts, modern plague vaccine development is ongoing. Subunit vaccines, for example, have been explored as they reduce the risk factors and adverse effects associated with live and killed whole-cell vaccines. However, thorough clinical trials are necessary to confirm the superiority and safety of these newer vaccines. Other vaccine types, such as recombinant protein vaccines and live attenuated vaccines, have also been developed to prevent the plague, specifically targeting the pneumonic plague, which is a deadly form of the disease.
In the absence of a commercially available vaccine, individuals can take preventive measures to reduce their risk of contracting the plague. This includes reducing exposure to rodents and other animals that may be infected, using flea control products, and wearing protective clothing when handling dead animals or skinning potentially infected animals.
The US TB Vaccination Program: A History Lesson
You may want to see also
Explore related products
The plague is caused by the Yersinia pestis bacterium, spread by fleas on rodents
The Black Death, or the bubonic plague, is caused by the Yersinia pestis bacterium, which is spread by fleas on rodents. It gets its name from the swollen lymph nodes (buboes) caused by the disease. The plague is an infectious disease that can affect both humans and animals and is spread primarily through fleas. Rats travelling on ships brought the plague to Europe during the Middle Ages, killing millions.
In the modern day, bubonic plague cases still occur worldwide and in the United States, with cases in Africa, Asia, South America, and western North America. In the U.S., most plague cases in humans occur in two areas: Northern New Mexico, northern Arizona, and southern Colorado; and another area involving California, southern Oregon, and western Nevada.
To prevent the plague, it is recommended to reduce exposure to rodents and other animals that may be infected, such as mice, rats, and squirrels. This includes removing clutter, brush, and potential rodent food sources from the home, workplace, and recreational areas. Additionally, flea control products can be used on pets, especially those that roam freely, and sick pets should be taken to the veterinarian immediately.
While there is no widely available vaccine for the plague, various types of vaccines have been developed and tested over the years. Inactivated bacterial vaccines have been used since 1890 but are less effective against the pneumonic plague. Live, attenuated vaccines and recombinant protein vaccines have been developed to address this issue. The first plague vaccine was created by bacteriologist Waldemar Haffkine in 1897, and he conducted a massive inoculation program in British India, distributing an estimated 26 million doses between 1897 and 1925 and reducing plague mortality by 50-85%.
Vaccine Shots: Can You Mix and Match?
You may want to see also
Explore related products
The plague is still endemic in many parts of the world
The bubonic plague, also known as the Black Death, is an infection caused by the Yersinia pestis (Y. pestis) bacterium. It is spread mostly by fleas on rodents and other animals. Humans who are bitten by infected fleas can contract the plague. The plague is infamous for killing millions of Europeans during the Middle Ages. It gets its name from the swollen lymph nodes (buboes) caused by the disease, which often resulted in blackened tissue due to gangrene.
The first plague vaccine was developed by bacteriologist Waldemar Haffkine in 1897. Between 1897 and 1925, an estimated 26 million doses of Haffkine's anti-plague vaccine were distributed from Bombay, reducing plague mortality by 50%-85%. This vaccine was a live whole cell (LWC)-based vaccine, which has since been used in the former Soviet Union and China for human vaccination. However, LWC vaccines are associated with adverse effects and do not provide long-term immunity.
Other types of vaccines, such as inactivated bacterial vaccines, have been used since 1890 but are less effective against the pneumonic plague. Formalin-killed whole-cell vaccines have also been developed and approved in the USA, but they are highly reactogenic, inefficient in providing long-term protection, and ineffective against pneumonic plague. While these vaccines can protect against bubonic plague, they are not suitable for use in a biothreat scenario.
New plague vaccines are currently in development, but they are not expected to be commercially available in the immediate future. In the meantime, people living in areas where the plague occurs can take steps to reduce their risk of infection, such as reducing rodent habitats around their homes and using repellent when exposed to fleas during outdoor activities.
Bill Gates Sterilization Formula: Myth or Reality?
You may want to see also
Frequently asked questions
There is currently no preventative vaccine available for the plague, also known as the Black Death. However, there is strong evidence for the efficacy of some vaccines in preventing or ameliorating the effects of the plague.
The Black Plague, or the Black Death, is an infection caused by a bacterium called Yersinia pestis (Y. pestis). It is spread to humans by infected fleas that travel on rodents. It gets its name from the blackened tissue caused by gangrene.
Symptoms of the plague include a sudden high fever and chills, pains in the abdomen, arms, and legs, and large swollen lumps in the lymph nodes that develop and leak pus.
